181 related articles for article (PubMed ID: 33529908)
1. Hydrogen sulfide exacerbated periodontal inflammation and induced autophagy in experimental periodontitis.
Ni K; Hua Y
Int Immunopharmacol; 2021 Apr; 93():107399. PubMed ID: 33529908
[TBL] [Abstract][Full Text] [Related]
2. H
Yurinskaya MM; Krasnov GS; Kulikova DA; Zatsepina OG; Vinokurov MG; Chuvakova LN; Rezvykh AP; Funikov SY; Morozov AV; Evgen'ev MB
Inflamm Res; 2020 May; 69(5):481-495. PubMed ID: 32157318
[TBL] [Abstract][Full Text] [Related]
3. GYY4137, a novel hydrogen sulfide-releasing molecule, protects against endotoxic shock in the rat.
Li L; Salto-Tellez M; Tan CH; Whiteman M; Moore PK
Free Radic Biol Med; 2009 Jul; 47(1):103-13. PubMed ID: 19375498
[TBL] [Abstract][Full Text] [Related]
4. Hydrogen sulfide donor GYY4137 attenuates vascular complications in mesenteric bed of streptozotocin-induced diabetic rats.
Alshahwan H; Qabazard B; Mousa A; Chandrasekhar B; Santhosh K; Yousif MHM
Eur J Pharmacol; 2022 Oct; 933():175265. PubMed ID: 36108734
[TBL] [Abstract][Full Text] [Related]
5. Effects of intranasal treatment with slow (GYY4137) and rapid (NaHS) donors of hydrogen sulfide in lipopolysaccharide-induced airway inflammation in mice.
Kaya-Yasar Y; Karaman Y; Bozkurt TE; Onder SC; Sahin-Erdemli I
Pulm Pharmacol Ther; 2017 Aug; 45():170-180. PubMed ID: 28645584
[TBL] [Abstract][Full Text] [Related]
6. GYY4137, a Slow-Releasing Hydrogen Sulfide Donor, Ameliorates Renal Damage Associated with Chronic Obstructive Uropathy.
Lin S; Visram F; Liu W; Haig A; Jiang J; Mok A; Lian D; Wood ME; Torregrossa R; Whiteman M; Lobb I; Sener A
J Urol; 2016 Dec; 196(6):1778-1787. PubMed ID: 27177428
[TBL] [Abstract][Full Text] [Related]
7. The route and timing of hydrogen sulfide therapy critically impacts intestinal recovery following ischemia and reperfusion injury.
Jensen AR; Drucker NA; Te Winkel JP; Ferkowicz MJ; Markel TA
J Pediatr Surg; 2018 Jun; 53(6):1111-1117. PubMed ID: 29622397
[TBL] [Abstract][Full Text] [Related]
8. Effects of fast versus slow-releasing hydrogen sulfide donors in hypertension in pregnancy and fetoplacental growth restriction.
Zochio GP; Possomato-Vieira JS; Chimini JS; da Silva MLS; Dias-Junior CA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Dec; 392(12):1561-1568. PubMed ID: 31363805
[TBL] [Abstract][Full Text] [Related]
9. Hydrogen sulfide ameliorates acute lung injury induced by infrarenal aortic cross-clamping by inhibiting inflammation and angiopoietin 2 release.
Tang B; Ma L; Yao X; Tan G; Han P; Yu T; Liu B; Sun X
J Vasc Surg; 2017 Feb; 65(2):501-508.e1. PubMed ID: 26781077
[TBL] [Abstract][Full Text] [Related]
10. Hydrogen sulfide alleviates hypertensive kidney dysfunction through an epigenetic mechanism.
Weber GJ; Pushpakumar SB; Sen U
Am J Physiol Heart Circ Physiol; 2017 May; 312(5):H874-H885. PubMed ID: 28213404
[TBL] [Abstract][Full Text] [Related]
11. Hydrogen sulfide impacts on inflammation-induced adipocyte dysfunction.
Comas F; Latorre J; Cussó O; Ortega F; Lluch A; Sabater M; Castells-Nobau A; Ricart W; Ribas X; Costas M; Fernández-Real JM; Moreno-Navarrete JM
Food Chem Toxicol; 2019 Sep; 131():110543. PubMed ID: 31154084
[TBL] [Abstract][Full Text] [Related]
12. The Proteasome Inhibitor Bortezomib Inhibits Inflammatory Response of Periodontal Ligament Cells and Ameliorates Experimental Periodontitis in Rats.
Jiang L; Song J; Hu X; Zhang H; Huang E; Zhang Y; Deng F; Wu X
J Periodontol; 2017 May; 88(5):473-483. PubMed ID: 27982724
[TBL] [Abstract][Full Text] [Related]
13. Chronic Treatment With Hydrogen Sulfide Donor GYY4137 Mitigates Microglial and Astrocyte Activation in the Spinal Cord of Streptozotocin-Induced Diabetic Rats.
Shayea AMF; Mousa AMA; Renno WM; Nadar MS; Qabazard B; Yousif MHM
J Neuropathol Exp Neurol; 2020 Dec; 79(12):1320-1343. PubMed ID: 33271602
[TBL] [Abstract][Full Text] [Related]
14. Treatment with hydrogen sulfide donor attenuates bone loss induced by modeled microgravity.
Yang M; Zhang K; Zhang X; Zhang Z; Yin X; He G; Li L; Yang X; He B
Can J Physiol Pharmacol; 2019 Jul; 97(7):655-660. PubMed ID: 30870598
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-21-Regulated Activation of the Akt Pathway Participates in the Protective Effects of H
Lu M; Jiang X; Tong L; Zhang F; Ma L; Dong X; Sun X
Biol Pharm Bull; 2018 Feb; 41(2):229-238. PubMed ID: 29187695
[TBL] [Abstract][Full Text] [Related]
16. GYY4137, a hydrogen sulfide‑releasing molecule, inhibits the inflammatory response by suppressing the activation of nuclear factor‑kappa B and mitogen‑activated protein kinases in Coxsackie virus B3‑infected rat cardiomyocytes.
Wu Z; Peng H; Du Q; Lin W; Liu Y
Mol Med Rep; 2015 Mar; 11(3):1837-44. PubMed ID: 25377925
[TBL] [Abstract][Full Text] [Related]
17. [Influence of the Donor of Hydrogen Sulfide GYY4137 on the Activation of Human Neutrophils by E. coli Lipopolysaccharides].
Petrushanko IY; Melnikova EV; Yurinskaya MM; Vinokurov MG; Suslikov AV; Mitkevich VA; Makarov AA
Mol Biol (Mosk); 2019; 53(1):101-108. PubMed ID: 30895957
[TBL] [Abstract][Full Text] [Related]
18. A slow-releasing donor of hydrogen sulfide inhibits neuronal cell death via anti-PANoptosis in rats with spinal cord ischemia‒reperfusion injury.
Xie L; Wu H; He Q; Shi W; Zhang J; Xiao X; Yu T
Cell Commun Signal; 2024 Jan; 22(1):33. PubMed ID: 38217003
[TBL] [Abstract][Full Text] [Related]
19. Parenteral Na
Drapala A; Koszelewski D; Tomasova L; Ostaszewski R; Grman M; Ondrias K; Ufnal M
Acta Biochim Pol; 2017; 64(3):561-566. PubMed ID: 28753683
[TBL] [Abstract][Full Text] [Related]
20. Chloroquine and 3-Methyladenine Attenuates Periodontal Inflammation and Bone Loss in Experimental Periodontitis.
He S; Zhou Q; Luo B; Chen B; Li L; Yan F
Inflammation; 2020 Feb; 43(1):220-230. PubMed ID: 31720989
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
